HPV (Human Papillomavirus)-AssociatedHPV-EducationNCT07320157
The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake
A study testing Online Education Intervention Group and Contral Group in people with HPV (Human Papillomavirus)-Associated and HPV Immunization Status, run by Ufuk University at 1 site in Turkey (Türkiye).
Trial summary
Type of Study: This study was planned to be an observational study. Purpose of the Study: To evaluate the impact of HPV education given to women on their knowledge levels and HPV screening and vaccination.The main question[s] it aims to answer [is/are]: H1: There is a difference in the mean Human Papillomavirus (HPV)… Read more about this study
- Who is it for?
- Ages 18 to 35 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- HPV (Human Papillomavirus)-Associated, HPV Immunization Status
- What is being tested?
- Online Education Intervention Group and Contral Group
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 59 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 9 Jan 2026to 23 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Being female
- Women aged 18-35 years
- Ability to speak and understand Turkish at a level sufficient to communicate with the researcher
- Having the technical equipment necessary to participate in a video interview
- No diagnosis of HPV positivity
- Not having received the HPV vaccine
Show all 10Show fewer
- Not having undergone HPV DNA/Pap smear testing in the past 5 years
- No diagnosis of cervical cancer
- Voluntary willingness to participate in the study
- No diagnosis of a psychiatric disorder
Who cannot join
- Being male
- Having severe physical or cognitive impairments that prevent completing the questionnaire
- Being under 18 years of age or over 35 years of age
- Inability to speak or understand Turkish
- Lack of technical equipment to participate in a video interview
- Having a diagnosis of HPV positivity
Show all 11Show fewer
- Having received the HPV vaccine
- Having undergone HPV DNA/Pap smear testing in the past 5 years
- Having a diagnosis of cervical cancer
- Having a diagnosed psychiatric disorder
- Not agreeing to participate in the study
Trial locations and contacts
1 site in 1 country.
About this study
Official title: "Women's HPV Education and Its Effects on Knowledge Levels, HPV Screening Behaviors, and HPV Vaccination Uptake: An Interventional Education Study"
Type of Study: This study was planned to be an observational study.
Purpose of the Study: To evaluate the impact of HPV education given to women on their knowledge levels and HPV screening and vaccination.The main question[s] it aims to answer [is/are]:
Read more
H1: There is a difference in the mean Human Papillomavirus (HPV) Knowledge Scale score between the intervention group women who participated in Human Papillomavirus (HPV) education and the control group women.
H2: There is a difference between the intervention group women and the control group women in terms of their participation in HPV screening tests.
H2: There is a difference between the intervention group women and the control group women in terms of their HPV vaccination status.
Participants Participants will be assigned to a control and intervention group. Online training will be provided to the intervention group, and the results of the training will be reported.
- Being tested
- Online Education Intervention Group, Contral Group
- Keywords
- HPV, WOMEN, HEALTH, VACCİNE
- Medical subject headings
- Papillomavirus Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Online Education Intervention GroupBehavioural
An online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after delivering the brochure, the questionnaire/scale forms will be administered to both groups as the first follow-up. Eight weeks after the first follow-up, the same forms will be administered again as the post-test. The WhatsApp group will remain open and interaction will be allowed throughout the research period.
Contral GroupOther
No intervention will be applied to the control group. Following the completion of the study, the brochure prepared on the topic will be sent to them via WhatsApp.
| Study group | Role | What they receive |
|---|---|---|
| Online Education Intervention Group | Experimental | An online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after delivering the brochure, the questionnaire/scale forms will be administered to both groups as the first follow-up. Eight weeks after the first follow-up, the same forms will be administered again as the post-test. The WhatsApp group will remain open and interaction will be allowed throughout the research period. Receives: Behavioral: Online Education Intervention Group; Other: Contral Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in HPV Knowledge Score
Change in participants' HPV Knowledge Scale scores measured at baseline, first follow-up, and final follow-up. The measure evaluates the effect of the online education and brochure intervention compared to the control group.
Measured: Baseline (before intervention), 2 weeks after brochure delivery (first follow-up), and 8 weeks after the first follow-up (final follow-up)
Secondary outcomes (1)
Sustained HPV Knowledge Score (Knowledge Retention)
Final follow-up (8 weeks after the first follow-up)
Measured: Knowledge retention will be assessed by comparing HPV Knowledge Scale scores between groups at the final follow-up. Higher scores indicate better long-term retention of information provided by the intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jan 2026
- Study start9 Jan 2026
- Primary completion23 Jan 2026
- Study completion23 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HPV (Human Papillomavirus)-AssociatedStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 59 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ufuk University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gizem Bilmez, Ufuk University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07320157
- Sponsor's protocol ID
- E-81182178-605-56406
- Acronym
- HPV-Education
- Status last verified
- Jul 2026
- First submitted
- 19 Dec 2025
- Last updated
- 30 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Due to privacy and confidentiality concerns of the participants, individual participant data will not be shared.
Study at a glance
From the registry record, last updated by the sponsor on 30 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- "Women's HPV Education and Its Effects on Knowledge Levels, HPV Screening Behaviors, and HPV Vaccination Uptake: An Interventional Education Study"
- ClinicalTrials.gov ID
- NCT07320157
- Acronym / sponsor ID
- HPV-Education / E-81182178-605-56406
- Keywords
- HPV, WOMEN, HEALTH, VACCİNE
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 59 participants (actual)
- Lead sponsor
- Ufuk UniversityUniversity, hospital or other
- Study start
- 9 Jan 2026 (actual)
- Primary completion
- 23 Jan 2026 (actual)
- Study completion
- 23 Apr 2026 (actual)
- First posted
- 6 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Type of Study: This study was planned to be an observational study.
Purpose of the Study: To evaluate the impact of HPV education given to women on their knowledge levels and HPV screening and vaccination.The main question[s] it aims to answer [is/are]:
H1: There is a difference in the mean Human Papillomavirus (HPV) Knowledge Scale score between the intervention group women who participated in Human Papillomavirus (HPV) education and the control group women.
H2: There is a difference between the intervention group women and the control group women in terms of their participation in HPV screening tests.
H2: There is a difference between the intervention group women and the control group women in terms of their HPV vaccination status.
Participants Participants will be assigned to a control and intervention group. Online training will be provided to the intervention group, and the results of the training will be reported.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Online Education Intervention Group | Experimental | Behavioral: Online Education Intervention Group, Other: Contral GroupAn online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after delivering the brochure, the questionnaire/scale forms will be administered to both groups as the first follow-up. Eight weeks after the first follow-up, the same forms will be administered again as the post-test. The WhatsApp group will remain open and interaction will be allowed throughout the research period. |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (10 listed)
- Being female
- Women aged 18-35 years
- Ability to speak and understand Turkish at a level sufficient to communicate with the researcher
- Having the technical equipment necessary to participate in a video interview
- No diagnosis of HPV positivity
Key exclusion criteria (11 listed)
- Being male
- Having severe physical or cognitive impairments that prevent completing the questionnaire
- Being under 18 years of age or over 35 years of age
- Inability to speak or understand Turkish
- Lack of technical equipment to participate in a video interview
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Online Education Intervention GroupAn online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after delivering the brochure, the questionnaire/scale forms will be administered to both groups as the first follow-up. Eight weeks after the first follow-up, the same forms will be administered again as the post-test. The WhatsApp group will remain open and interaction will be allowed throughout the research period. | Behavioural | Online Education Intervention Group |
| Contral GroupNo intervention will be applied to the control group. Following the completion of the study, the brochure prepared on the topic will be sent to them via WhatsApp. | Other | Online Education Intervention Group |
Primary outcome
Change in HPV Knowledge Score
Time frame: Baseline (before intervention), 2 weeks after brochure delivery (first follow-up), and 8 weeks after the first follow-up (final follow-up)
Change in participants' HPV Knowledge Scale scores measured at baseline, first follow-up, and final follow-up. The measure evaluates the effect of the online education and brochure intervention compared to the control group.
1 secondary outcome
Sustained HPV Knowledge Score (Knowledge Retention)
Time frame: Knowledge retention will be assessed by comparing HPV Knowledge Scale scores between groups at the final follow-up. Higher scores indicate better long-term retention of information provided by the intervention.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jul 2026.
- Individual participant dataSharing planned: No. Due to privacy and confidentiality concerns of the participants, individual participant data will not be shared.
Related trials for HPV (Human Papillomavirus)-Associated
RecruitingPhase 2
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Head and Neck Cancer, Head and Neck Squamous Cell Cancer
Not yet recruiting
C2001P-CS3: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
Human Papillomavirus (HPV), HPV Associated Cancers
Not yet recruiting
The Effect of Health Belief Model-Based HPV Infection and Vaccination Education on University Students' Knowledge and Health Beliefs
Health Belief Model, Nursing Students
Not yet recruitingPhase 1/2
Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs
HPV Positive Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma
RecruitingPhase 2
Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
HPV (Human Papillomavirus)-Associated, Genital Warts
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Online Education Intervention Group and Contral Group in people with HPV (Human Papillomavirus)-Associated and HPV Immunization Status, run by Ufuk University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in HPV Knowledge Score (time frame: Baseline (before intervention), 2 weeks after brochure delivery (first follow-up), and 8 weeks after the first follow-up (final follow-up)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2026; AzTrials last refreshed its copy on 8 Nov 2026.